Pancreatic Cancer Research

ResearcherWangjing Hospital of China Academy of Chinese Medical SciencesNo recent work listed

Fang Wang

Matched on ORCID iD 0000-0003-3538-9661; OpenAlex author ID A5100321476.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer. Last author DOI 10.12998/wjcc.v10.i27.9703↗
  2. Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. Co-author DOI 10.3978/j.issn.2305-5839.2015.11.17↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Zhonghui Li · 1 shared paper, 2022
  2. Shiyang Pan · 1 shared paper, 2015
  3. Lei Wu · 1 shared paper, 2015

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.